Humana ( HUM) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.1%. By the end of trading, Humana fell $2.26 (-2.6%) to $82.93 on light volume. Throughout the day, 1,190,501 shares of Humana exchanged hands as compared to its average daily volume of 2,085,900 shares. The stock ranged in price between $82.33-$85.22 after having opened the day at $85.00 as compared to the previous trading day's close of $85.19. Other companies within the Health Care sector that declined today were: Pingtan Marine Enterprise ( PME), down 61.6%, Mast Therapeutics ( MSTX), down 39.8%, Achillion Pharmaceuticals ( ACHN), down 25.1% and SunLink Health Systems ( SSY), down 12.1%.

Humana Inc., a health care company, offers insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Health and Well-Being Services. Humana has a market cap of $13.3 billion and is part of the health services industry. The company has a P/E ratio of 9.5, below the S&P 500 P/E ratio of 17.7. Shares are up 24.1% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Ambit Biosciences ( AMBI), up 18.2%, Aoxing Pharmaceutical Company ( AXN), up 13.9%, Celldex Therapeutics ( CLDX), up 12.3% and Puma Biotechnology ( PBYI), up 12.3% , were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.